Traditional risk markers for CVDs such as age, waist circumference, systolic blood pressure, diastolic blood pressure, ApoB/ApoA1 ratio, total leukocyte count, neutrophil to lymphocyte ratio (NLR), as well as the proportion of men, smokers, history of CHD, history of anti-hypertensive medication, and history of anti-lipid medication were all higher in subjects who developed AAA compared to those who did not. This evidence concerns the gene APOA1 and coronary artery disorder.